1-AM

• Description :

  A potent, selective, covalent KRAS G12C inhibitor that selectively inhibit KRAS G12C-dependent signaling and cancer cell growth at sub-micromolar concentrations.

• Stability :

  ≥ 2 years

• Purity :

  >98% (HPLC)

• Weight :

  510.998

• Molecular Formula :

  C26H28ClFN6O2

• Notes :

  Research use only, not for human use.

• Receptor :

  Ras